⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RPRX News
Royalty Pharma plc Class A Ordinary Shares
Royalty Pharma declares fourth quarter 2026 dividend
globenewswire.com
RPRX
Blood Cancer United Presents Inaugural Breakthrough Voice and Breakthrough Rising Leader Awards at First-Ever Night of Champions
prnewswire.com
LLY
RPRX
Royalty Pharma to announce third quarter 2026 financial results on November 4, 2026
globenewswire.com
RPRX
Royalty Pharma announces $7.5 million gift to Blood Cancer United to expand Therapy Acceleration Program
globenewswire.com
RPRX
KURA
Blood Cancer United Announces $7.5 Million Gift From Royalty Pharma to Expand Therapy Acceleration Program
prnewswire.com
RPRX
KURA
Royalty Pharma to present at upcoming investor conferences
globenewswire.com
RPRX
Royalty Pharma announces update on Novartis’ Phase 3 topline results for pelacarsen
globenewswire.com
RPRX
Oncolytic Virus Cancer Therapy Market Expected to Expand Rapidly During the Forecast Period (2026-2036) Amid Rising Investments in Next-Generation Cancer Treatments| DelveInsight
prnewswire.com
AMGN
CGON
CLNN
RPRX
BTAI
ONCY
Royalty Pharma and Zealand Pharma enter into rusfertide funding agreement for $100 million
globenewswire.com
RPRX
Zealand Pharma enters into a USD 100 million royalty purchase and sale agreement with Royalty Pharma for the economics related to rusfertide
globenewswire.com
RPRX